Nutlin-3 treatment of all cutaneous melanoma lines resulted in a strong decrease in mRNA levels of the tested genes downregulated upon MDMX depletion (Supplementary Figure S3B). This evidence concerns the gene MDM4 and cutaneous melanoma.